 |
 |
BIOTHERAPEUTICS |
| |
USV
has been successful in developing therapeutic proteins
and peptides by recombinant* and chemical synthesis processes.
These include hGH, Enterokinase, hG-CSF, Teriparatide and Nesiritide which
have been developed using recombinant DNA (rDNA) technology and
Eptifibatide and Bivalirudin, by chemical synthesis.
| Product |
Status |
| Eptifibatide |
Commercialized |
| Enterokinase |
Commercialized |
| Bivalirudin |
Ready to be Commercialized |
| rhGH |
Clinicals |
| Nesiritide |
Clinicals |
| Teriparatide |
Pre-clinicals |
| rhG-CSF |
Pre-clinicals |
| PDGF-BB |
Pre-clinicals |
| PEG-IFN |
Scale-up |
|
* We are open to third party product development using our expression platforms. Contact us for details.
Disclaimer: Products under patents are offered
for sale only in those countries where patents have expired. |
|
|
|
|
